Clinical Trials Directory

Trials / Completed

CompletedNCT01845363

Antibiotic Prophylaxis in Bariatric Surgery With Cefazolin: Concentration in Adipose Tissue

Antibiotic Prophylaxis in Bariatric Surgery With Continuous Infusion of Cefazolin: Determination of Concentration in Adipose Tissue

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Universidade Federal de Pernambuco · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Eighteen patients were given a dose of 2g Cefazolin in anesthetic induction, supplemented with 1g delivered through continuous infusion during surgery. Adipose samples, obtained at the beginning and end of surgery, were analyzed using high performance liquid chromatography. Some published studies suggest that the dose of 2g does not supply the minimum inhibitory concentration for principal causal agents of surgical site infection. To determine the concentration of Cefazolin in adipose tissue of patients undergoing bariatric surgery and to evaluate the relationship between concentrations obtained and body mass index (BMI).

Conditions

Interventions

TypeNameDescription
DRUGCefazolin used in antimicrobial prophylaxisCefazolin administered a first dose of 2g in anesthetic induction, followed by continuous dosage of 1g diluted in 250mL of saline solution for two hours. Two samples of subcutaneous tissue were collected for analysis: the first soon after the incision, and a second before skin synthesis. The samples were processed by HPLC.

Timeline

Start date
2011-06-01
Primary completion
2011-10-01
Completion
2012-05-01
First posted
2013-05-03
Last updated
2013-05-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01845363. Inclusion in this directory is not an endorsement.